Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Source:
techcrunch
November 17, 2026 · 06:50
From the publisher
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
About the source
TechCrunch
TechCrunch is an American global online newspaper focusing on topics regarding high-tech and startup companies. It was founded in June 2005 by Archimedes Ventures, led by partners Michael Arrington and Keith Teare. In 2010, AOL acquired the company for approximately $25 million. Following the 2015 acquisition of AOL and Yahoo! by Verizon, the site was owned by Verizon Media from 2015 through 2021.
Wikidata Q1022366
Wikidata ↗
The original article opens on the publisher's website.
More from General
View topic →Nvidia Has No Plans to Bring Back Jensen Huang
nytimes
Nov 17, 2026 · 16:27
Microsoft calls Copilot "the new OS for work" at Ignite keynote
arsTechnica
Nov 17, 2026 · 16:27
Nvidia promises that revenue will keep soaring — for now
techcrunch
Nov 17, 2026 · 16:16
Stripe backer Atomico calls for Europe to own its success stories
techcrunch
Nov 17, 2026 · 16:01
Europe plans to catch the next computer chip wave
bbcTechnology
Nov 17, 2026 · 16:00